MacroGenics, Inc.
MGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $203,519 | $595,759 | $412,090 | $962,113 |
| - Cash | $182,840 | $100,956 | $108,884 | $123,469 |
| + Debt | $37,461 | $33,971 | $34,832 | $25,468 |
| Enterprise Value | $58,140 | $528,774 | $338,038 | $864,112 |
| Revenue | $148,339 | $57,193 | $150,018 | $75,643 |
| % Growth | 159.4% | -61.9% | 98.3% | – |
| Gross Profit | $136,040 | $48,971 | $142,634 | $72,992 |
| % Margin | 91.7% | 85.6% | 95.1% | 96.5% |
| EBITDA | -$57,367 | $2,017 | -$107,893 | -$190,857 |
| % Margin | -38.7% | 3.5% | -71.9% | -252.3% |
| Net Income | -$66,966 | -$9,058 | -$119,758 | -$202,115 |
| % Margin | -45.1% | -15.8% | -79.8% | -267.2% |
| EPS Diluted | -1.07 | -0.15 | -1.95 | -3.18 |
| % Growth | -613.3% | 92.3% | 38.7% | – |
| Operating Cash Flow | -$68,373 | -$78,205 | -$86,959 | -$143,830 |
| Capital Expenditures | -$3,706 | -$1,764 | -$3,623 | -$6,201 |
| Free Cash Flow | -$72,079 | -$79,969 | -$90,582 | -$150,031 |